SciSight Ecosystem
WoS SCIE Q1Scopus Q1SCImago #3,235CAS 2区Hybrid

Drug Delivery and Translational Research

Abbreviation (ISO):DRUG DELIV TRANSL RE
Country: Germany•WoS SCIE Quartile: Q1•Scopus SJR: 1.28•SCImago Rank: #3,235•Identifier (ISSN):2190-393X(Print)/2190-3948(Online)•Articles / Year: 211•Estimated Publication Fee (APC): $3,337 USD
Clarivate IF (2026)Q1
6.9
↑ +1.4

Leading citation impact metric from Clarivate Journal Citation Reports

JCR Release Date: 2026-06-17
H-Index (2021)
27

27 papers with at least that number of citations each

WoS: SCIE / JCRQ1
Self-Citation Rate1.8%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
211articles/year
39.34% Gold OA•80.46% Original Research

State Council for Professorship (HĐGSNN) Scoring

Quyết định số 26/QĐ-HĐGSNN ngày 11/7/2025 (Mục quốc tế)

3.00pts
Latest Max Score
Estimated (Dec 26)
Scoring Basis: WoS Q1 có IF ≥ 5.0(IF: 6.9)

HĐGSNN Score History

By article publication year
YearMax ScoreEvaluation DetailsSource
20263.00đ
WoS Q1 có IF ≥ 5.0(IF: 6.9)
🔵 Computed
20253.00đ
WoS Q1 có IF ≥ 5.0(IF: 5.5)
🔵 Computed
20243.00đ
WoS Q1 có IF ≥ 5.0(IF: 5.7)
🔵 Computed
20233.00đ
WoS Q1 có IF ≥ 5.0(IF: 5.4)
🔵 Computed
20223.00đ
WoS Q1 có IF ≥ 5.0(IF: 5.671)
🔵 Computed
20212.50đ
WoS Q1 có IF ≥ 3.0(IF: 4.617)
🔵 Computed
20202.00đ
WoS Q1(IF: 2.664)
🔵 Computed
20192.50đ
WoS Q1 có IF ≥ 3.0(IF: 3.111)
🔵 Computed
20182.50đ
WoS Q1 có IF ≥ 3.0(IF: 3.395)
🔵 Computed

Note: Domestic journal scores are officially collected from annual HĐGSNN decisions across councils. International journal scores are dynamically computed according to Decision 26/QĐ-HĐGSNN based on quartile and citation metrics in the publication year.

Aims & Scope

The journal provides a unique forum for scientific publication of high-quality research that is exclusively focused on translational aspects of drug delivery. Rationally developed, effective delivery systems can potentially affect clinical outcome in different disease conditions. Research focused on the following areas of translational drug delivery research will be considered for publication in the journal. Designing and developing novel drug delivery systems, with a focus on their application to disease conditions; Preclinical and clinical data related to drug delivery systems; Drug distribution, pharmacokinetics, clearance, with drug delivery systems as compared to traditional dosing to demonstrate beneficial outcomes Short-term and long-term biocompatibility of drug delivery systems, host response; Biomaterials with growth factors for stem-cell differentiation in regenerative medicine and tissue engineering; Image-guided drug therapy, Nanomedicine; Devices for drug delivery and drug/device combination products. In addition to original full-length papers, communications, and reviews, the journal includes editorials, reports of future meetings, research highlights, and announcements pertaining to the activities of the Controlled Release Society.

Topics Covered (Recognized by AI)
Biology94.1%Medicine91.3%Chemistry90%Organic chemistry68.4%Materials science68.4%Genetics67.6%Biochemistry63.9%Pharmacology62.4%Engineering59.1%Nanotechnology56.2%Internal medicine54.8%Physics52.3%Chemical engineering45.4%Psychology39.9%Drug delivery39%Psychiatry34.6%Quantum mechanics31.5%Drug28.5%Biotechnology27.5%Pathology27.3%Immunology26%Bioinformatics25.5%Composite material24.2%Chromatography24.2%In vivo23.8%Nanoparticle23%In vitro22%Endocrinology21%Surgery20.5%

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #3,235Scopus Q1SCImago Profile
Scopus Coverage:2011-2026
Scopus Broad Areas:Pharmacology, Toxicology and Pharmaceutics
Scopus Citation Rank (SJR)Q1
1.28

Weighted prestige citation metric per document indexed in the Scopus database.

Tứ phân vị: Scopus Q1
Scopus H-Index (2025)
81

Measures cumulative publication volume and citation impact.

Scopus Database Indexed (2025)
Citations / Doc (2 years)
7.83

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$3,337 USD

Estimated Article Processing Charge for Open Access publication.

Chi phí ước tính / bài báo

Scopus 3-Year Publication & Citation Window

3-Year Citations5,320
3-Year Documents625
Citable Documents613

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)1

Citations in government and international policy documents

Female Author Rate48.2%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Pharmaceutical ScienceQ1

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
2区 (Zone 2)Medicine
Minor Category (Specific Field):
3区MEDICINE, RESEARCH & EXPERIMENTAL
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Publisher Review Speed
Updating
Average time to first editorial decision
Online Publication Speed
Updating
Time from acceptance to online publication
Official Acceptance Rate
Updating
Manuscript acceptance rate confirmed by the publisher
Open Access Model
Hybrid
OA publishing option or traditional subscription
Publisher
Springer US
Publication Language
English
Frequency
12 issues per year
Founding Year
2011
Editorial Address
TIERGARTENSTRASSE 17, HEIDELBERG, GERMANY, D-69121
Indexing & Databases
SCIEScopusPubMed

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
CategoryIndexRankQuartile
MEDICINE, RESEARCH & EXPERIMENTAL
JCRSCIE
35/191Q1
PHARMACOLOGY & PHARMACY
JCRSCIE
34/356Q1
MEDICINE, RESEARCH & EXPERIMENTAL
JCISCIE
28/191Q1
PHARMACOLOGY & PHARMACY
JCISCIE
36/356Q1

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
YearImpact FactorArticles / YearTotal Citations
2026—190148
20255.52601,375
20245.72673,746
20235.42153,796
20225.6711835,311
20214.6172239,113
20202.6641777,396
20193.111873,458
20183.3951435,302
2017—1183,716
2016—783,463
2015—603,085
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Impact Factor Trend (2018–2024)

Clarivate IF trend for Drug Delivery and Translational Research

WoS Q1
1357201820192020202120222023202420255.50
Annual Impact Factor Metric
2025:5.5

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 1.8%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: d0daba91-5542-463b-b36c-89ed0c3dfb41
Database Updated: 2026-10-01